Giancarlo Allocca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giancarlo Allocca has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Meghan Haire
Center for Neuroscience, Biosciences Division, SRI International
2 shared publications - Ryan K. Tisdale
SRI International
2 shared publications - Shun-Chieh Ma
Center for Neuroscience, Biosciences Division, SRI International
2 shared publications - Stephen R. Morairty
SRI Biosciences, Center for Neuroscience, Menlo Park, USA
2 shared publications - Sunmee Park
Center for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA 94025, USA
2 shared publications - Thomas S. Kilduff
Biosciences Division, SRI International, Menlo Park, USA
2 shared publications
Latest Publications
- Open Access
Automated sleep scoring in hibernating and non-hibernating American black bears
Hibernating bears show remarkable metabolic suppression. Their decline in core body temperature (T b ) is moderate (from 38°C to 30-35°C), but their metabolism declines as much as 75%. To understand the role of sleep in this hypometabolic state, we recorded biotelemetrically EEG, EOG and EMG data over 3500 days from 16 captive American black bears in and out of hibernation under semi-natural conditions. This data set is too large to score manually for Wake, REM- and NREM sleep, so we tested two machine learning classifiers: (1) Somnotate trained on multiple one-day recordings, and (2) Somnivore, trained on a small subset from each recording. As automated scoring methods have not been applied to hibernating species before, a major concern is the effect changing brain temperature has on the EEG and on the machine learning based detection. Therefore, we selected reference data using consensus by 3 manual sleep scorers from each of 6 bears, two one-day recordings at the highest and lowest body temperatures during hibernation when T b was oscillating in multiday cycles, and a non-hibernating one-day recording in summer. Somnotate results were excellent when trained separately for hibernating and non-hibernating data. Training Somnotate separately for high and low T b within hibernation did not improve results further. Sleep times in hibernation were about 2x that in summer for both automated scores and manual scores (p0.05), but a small overestimate of sleep time in summer (p<0.05). Both applications yielded F-measures against manual scores in the 0.90-0.98 range. Outliers in the 0.67-0.88 range were correlated between the two applications, indicating that specific files are more challenging to annotate. We conclude that both applications have accuracies approaching that of manual scorers when trained on high quality data.
Open AccessAutomated sleep scoring in hibernating and non-hibernating American black bears
Hibernating bears show remarkable metabolic suppression. Their decline in core body temperature (T b ) is moderate (from 38°C to 30-35°C), but their metabolism declines as much as 75%. To understand the role of sleep in this hypometabolic state, we recorded biotelemetrically EEG, EOG and EMG data over 3500 days from 16 captive American black bears in and out of hibernation under semi-natural conditions. This data set is too large to score manually for Wake, REM- and NREM sleep, so we tested two machine learning classifiers: (1) Somnotate trained on multiple one-day recordings, and (2) Somnivore, trained on a small subset from each recording. As automated scoring methods have not been applied to hibernating species before, a major concern is the effect changing brain temperature has on the EEG and on the machine learning based detection. Therefore, we selected reference data using consensus by 3 manual sleep scorers from each of 6 bears, two one-day recordings at the highest and lowest body temperatures during hibernation when T b was oscillating in multiday cycles, and a non-hibernating one-day recording in summer. Somnotate results were excellent when trained separately for hibernating and non-hibernating data. Training Somnotate separately for high and low T b within hibernation did not improve results further. Sleep times in hibernation were about 2x that in summer for both automated scores and manual scores (p0.05), but a small overestimate of sleep time in summer (p<0.05). Both applications yielded F-measures against manual scores in the 0.90-0.98 range. Outliers in the 0.67-0.88 range were correlated between the two applications, indicating that specific files are more challenging to annotate. We conclude that both applications have accuracies approaching that of manual scorers when trained on high quality data.
- Open Access
- 20 September 2023
- Published by Wiley in Journal of Sleep Research
- Vol. 33 (3) , e14037
Biological sex influences sleep phenotype in mice experiencing spontaneous opioid withdrawal
Summary: Aversive symptoms, including insomnia experienced during opioid withdrawal, are a major drive to relapse; however, withdrawal‐associated sleep symptomatology has been little explored in preclinical models. We describe here a model of opioid withdrawal in mice that resembles the sleep phenotype characteristic of withdrawal in humans. Male and female C57BL/6 mice were instrumented with telemeters to record electroencephalogram, electromyogram, activity and subcutaneous temperature. All mice received two treatments separated by a 16‐day washout period: (1) saline (volume: 10 ml kg−1); or (2) ascending doses of morphine (5, 10, 20, 40 and 80 mg kg−1; volume: 10 ml kg−1) for 5 days at Zeitgeber time 1 and Zeitgeber time 13. Recordings for the first 71 hr after treatment discontinuation (withdrawal days 1–3) and for 24 hr on withdrawal days 5 and 7 were scored for sleep/wake state, and sleep architecture and electroencephalogram spectral data were analysed. Morphine was acutely wake‐ and activity‐promoting, and non‐rapid eye movement and rapid eye movement sleep were increased during the dark phase on withdrawal day 2 in both sexes. While non‐rapid eye movement delta power (0.5–4.0 Hz), a measure of sleep intensity, was reduced during the light phase on withdrawal day 1 and the dark phase on withdrawal day 2 in both sexes, female mice also exhibited changes in the duration and the number of bouts of sleep/wake states. These observations of fragmented sleep on withdrawal days 1–3 suggest poorer sleep consolidation and a more pronounced withdrawal‐associated sleep phenotype in female than in male mice. These data may indicate a greater sensitivity to morphine, a more distinct aversive sleep phenotype and/or a faster escalation to dependence in female mice.
- 20 September 2023
- Published by Wiley in Journal of Sleep Research
- Vol. 33 (3) , e14037
Open AccessBiological sex influences sleep phenotype in mice experiencing spontaneous opioid withdrawal
Summary: Aversive symptoms, including insomnia experienced during opioid withdrawal, are a major drive to relapse; however, withdrawal‐associated sleep symptomatology has been little explored in preclinical models. We describe here a model of opioid withdrawal in mice that resembles the sleep phenotype characteristic of withdrawal in humans. Male and female C57BL/6 mice were instrumented with telemeters to record electroencephalogram, electromyogram, activity and subcutaneous temperature. All mice received two treatments separated by a 16‐day washout period: (1) saline (volume: 10 ml kg−1); or (2) ascending doses of morphine (5, 10, 20, 40 and 80 mg kg−1; volume: 10 ml kg−1) for 5 days at Zeitgeber time 1 and Zeitgeber time 13. Recordings for the first 71 hr after treatment discontinuation (withdrawal days 1–3) and for 24 hr on withdrawal days 5 and 7 were scored for sleep/wake state, and sleep architecture and electroencephalogram spectral data were analysed. Morphine was acutely wake‐ and activity‐promoting, and non‐rapid eye movement and rapid eye movement sleep were increased during the dark phase on withdrawal day 2 in both sexes. While non‐rapid eye movement delta power (0.5–4.0 Hz), a measure of sleep intensity, was reduced during the light phase on withdrawal day 1 and the dark phase on withdrawal day 2 in both sexes, female mice also exhibited changes in the duration and the number of bouts of sleep/wake states. These observations of fragmented sleep on withdrawal days 1–3 suggest poorer sleep consolidation and a more pronounced withdrawal‐associated sleep phenotype in female than in male mice. These data may indicate a greater sensitivity to morphine, a more distinct aversive sleep phenotype and/or a faster escalation to dependence in female mice.
- Open Access
The Development of Sleep/Wake Disruption and Cataplexy as Hypocretin/Orexin Neurons Degenerate in Male vs. Female Orexin/tTA; TetO-DTA Mice
Narcolepsy Type 1 (NT1), a sleep disorder with similar prevalence in both sexes, is thought to be due to loss of the hypocretin/orexin (Hcrt) neurons. Several transgenic strains have been created to model this disorder and are increasingly being used for preclinical drug development and basic science studies, yet most studies have solely used male mice. We compared the development of narcoleptic symptomatology in male vs. female orexin-tTA; TetO-DTA mice, a model in which Hcrt neuron degeneration can be initiated by removal of doxycycline (DOX) from the diet. EEG, EMG, body temperature, gross motor activity and video recordings were conducted for 24-h at baseline and 1, 2, 4 and 6 weeks after DOX removal. Female DTA mice exhibited cataplexy, the pathognomonic symptom of NT1, by Week 1 in the DOX(-) condition but cataplexy was not consistently present in males until Week 2. By Week 2, both sexes showed an impaired ability to sustain long wake bouts during the active period, the murine equivalent of excessive daytime sleepiness in NT1. Body temperature appeared to be regulated at lower levels in both sexes as the Hcrt neurons degenerated. During degeneration, both sexes also exhibited the “Delta State”, characterized by sudden cessation of activity, high delta activity in the EEG, maintenance of muscle tone and posture, and the absence of phasic EMG activity. Since the phenotypes of the two sexes were indistinguishable by Week 6, we conclude that both sexes can be safely combined in future studies to reduce cost and animal use. Statement of Significance: Although narcolepsy is a disorder that affects both men and women with similar frequency, most basic research and preclinical development studies of sleep have utilized male experimental subjects. The identification of the hypocretin/orexin (Hcrt) neuron loss as the likely cause of human narcolepsy has led to the development of transgenic mouse strains that model this disorder. Here, we compare the emergence of narcoleptic symptoms in male vs. female bigenic orexin-tTA; TetO DTA mice, a state-of-the-art narcolepsy model in which degeneration of the Hcrt neurons can be triggered by dietary manipulation. We find that female mice develop the narcoleptic phenotype more rapidly than males but that both sexes are equally symptomatic by the end of the degeneration period.
Open AccessThe Development of Sleep/Wake Disruption and Cataplexy as Hypocretin/Orexin Neurons Degenerate in Male vs. Female Orexin/tTA; TetO-DTA Mice
Narcolepsy Type 1 (NT1), a sleep disorder with similar prevalence in both sexes, is thought to be due to loss of the hypocretin/orexin (Hcrt) neurons. Several transgenic strains have been created to model this disorder and are increasingly being used for preclinical drug development and basic science studies, yet most studies have solely used male mice. We compared the development of narcoleptic symptomatology in male vs. female orexin-tTA; TetO-DTA mice, a model in which Hcrt neuron degeneration can be initiated by removal of doxycycline (DOX) from the diet. EEG, EMG, body temperature, gross motor activity and video recordings were conducted for 24-h at baseline and 1, 2, 4 and 6 weeks after DOX removal. Female DTA mice exhibited cataplexy, the pathognomonic symptom of NT1, by Week 1 in the DOX(-) condition but cataplexy was not consistently present in males until Week 2. By Week 2, both sexes showed an impaired ability to sustain long wake bouts during the active period, the murine equivalent of excessive daytime sleepiness in NT1. Body temperature appeared to be regulated at lower levels in both sexes as the Hcrt neurons degenerated. During degeneration, both sexes also exhibited the “Delta State”, characterized by sudden cessation of activity, high delta activity in the EEG, maintenance of muscle tone and posture, and the absence of phasic EMG activity. Since the phenotypes of the two sexes were indistinguishable by Week 6, we conclude that both sexes can be safely combined in future studies to reduce cost and animal use. Statement of Significance: Although narcolepsy is a disorder that affects both men and women with similar frequency, most basic research and preclinical development studies of sleep have utilized male experimental subjects. The identification of the hypocretin/orexin (Hcrt) neuron loss as the likely cause of human narcolepsy has led to the development of transgenic mouse strains that model this disorder. Here, we compare the emergence of narcoleptic symptoms in male vs. female bigenic orexin-tTA; TetO DTA mice, a state-of-the-art narcolepsy model in which degeneration of the Hcrt neurons can be triggered by dietary manipulation. We find that female mice develop the narcoleptic phenotype more rapidly than males but that both sexes are equally symptomatic by the end of the degeneration period.